Sample size review in a head injury tria
โ
K. Bolland; M. R. Sooriyarachchi; J. Whitehead
๐
Article
๐
1998
๐
John Wiley and Sons
๐
English
โ 109 KB
๐ 1 views
Between 1993 and 1996, a total of 452 patients were entered into a randomized trial evaluating eliprodil (a non-competitive NMDA receptor antagonist) in patients suffering from severe head injury. The primary efficacy analysis concerned the Glasgow Outcome Score (GOS), six months after randomization